Esther C. van den Broek

Molecular Subtypes of Pulmonary Large-cell Neuroendocrine Carcinoma Predict Chemotherapy Treatment Outcome

Jules L. Derks, Noémie Leblay, Erik Thunnissen et al. · Clinical Cancer Research · 2017 · 216 citations · Full text

Salivary gland pleomorphic adenoma in the Netherlands: A nationwide observational study of primary tumor incidence, malignant transformation, recurrence, and risk factors for recurrence

Matthijs H. Valstar, Mischa de Ridder, Esther C. van den Broek et al. · Oral Oncology · 2017 · 139 citations · Full text

Chemotherapy for pulmonary large cell neuroendocrine carcinomas: does the regimen matter?

Jules L. Derks, Robert Jan van Suylen, Erik Thunnissen et al. · European Respiratory Journal · 2017 · 113 citations · Full text

Extent of ductal carcinoma in situ according to breast cancer subtypes: a population-based cohort study

Shusma C. Doebar, Esther C. van den Broek, Linetta B. Koppert et al. · Breast Cancer Research and Treatment · 2016 · 67 citations · Full text

DLL3 expression in large cell neuroendocrine carcinoma (LCNEC) and association with molecular subtypes and neuroendocrine profile

B.C.M. Hermans, Jules L. Derks, Erik Thunnissen et al. · Lung Cancer · 2019 · 60 citations · Full text

Molecular Subtypes, Glioma, Neuroendocrine Profile +10